
IQVIA Holdings IQV
$ 163.7
0.92%
Annual report 2025
added 02-17-2026
IQVIA Holdings Operating Expenses 2011-2026 | IQV
Annual Operating Expenses IQVIA Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 2.94 B | 2.86 B | 2.62 B | 1.3 B | 921 M | 882 M | 861 M | 818 M | 762 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.94 B | 762 M | 1.55 B |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
1.99 B | $ 116.13 | 0.51 % | $ 35.3 B | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
50.6 M | $ 1.64 | -1.8 % | $ 2.18 M | ||
|
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 25.51 | 4.29 % | $ 709 M | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
CareDx, Inc
CDNA
|
411 M | $ 21.53 | 1.39 % | $ 1.15 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | ||
|
Illumina
ILMN
|
3.69 B | $ 127.88 | - | $ 20.3 B | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 15.96 | -2.15 % | $ 483 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 173.08 | 1.95 % | $ 8.58 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
226 M | $ 90.12 | 1.36 % | $ 11.3 B | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 83.88 | -0.53 % | $ 5.66 B | ||
|
Medpace Holdings
MEDP
|
118 M | $ 415.61 | 1.23 % | $ 12 B | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
20 M | $ 1.91 | -3.29 % | $ 8.45 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.57 | 0.35 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | ||
|
Senseonics Holdings
SENS
|
61.8 M | $ 7.04 | -0.14 % | $ 294 M | ||
|
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 9.49 | -0.47 % | $ 2.06 B | ||
|
Soleno Therapeutics
SLNO
|
181 M | $ 52.73 | 0.01 % | $ 2.68 B | ||
|
Biomerica
BMRA
|
5.64 M | $ 2.14 | - | $ 4.92 M | ||
|
National Research Corporation
NRC
|
38.5 M | $ 17.17 | -0.35 % | $ 384 M | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 100.45 | -1.68 % | $ 8.29 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 263.57 | -0.06 % | $ 21.9 B | ||
|
Thermo Fisher Scientific
TMO
|
7.15 B | $ 470.21 | 0.14 % | $ 177 B | ||
|
Celcuity
CELC
|
172 M | $ 124.3 | 2.7 % | $ 5.81 B | ||
|
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.68 | 4.37 % | $ 61.9 M | ||
|
OpGen
OPGN
|
21.9 M | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
430 M | $ 8.46 | 1.99 % | $ 1.08 B | ||
|
Twist Bioscience Corporation
TWST
|
116 M | $ 60.08 | -1.41 % | $ 3.59 B | ||
|
Myriad Genetics
MYGN
|
964 M | $ 4.75 | -0.73 % | $ 440 M | ||
|
Natera
NTRA
|
258 M | $ 206.37 | 1.29 % | $ 20.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 197.17 | 0.49 % | $ 21.9 B | ||
|
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | ||
|
PerkinElmer
PKI
|
1.07 B | - | -0.91 % | $ 14.7 B |